Literature DB >> 29144598

Estimating burden of influenza-associated influenza-like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12-2015/16 influenza seasons.

Giedre Gefenaite1,2, Adriana Pistol3, Rodica Popescu3, Odette Popovici3, Daniel Ciurea4, Christiaan Dolk1,5, Mark Jit6, Diane Gross1.   

Abstract

BACKGROUND: Influenza is responsible for substantial morbidity and mortality, but there is limited information on reliable disease burden estimates, especially from middle-income countries in the WHO European Region.
OBJECTIVES: To estimate the incidence of medically attended influenza-associated influenza-like illness (ILI) and hospitalizations due to severe acute respiratory infection (SARI) presenting to public healthcare facilities in Romania. PATIENTS/
METHODS: Sentinel influenza surveillance data for ILI and SARI from 2011/12-2015/16, including virological data, were used to estimate influenza-associated ILI and SARI incidence/100 000 and their 95% confidence intervals (95% CI).
RESULTS: The overall annual incidence of ILI and influenza-associated ILI per 100 000 persons in Romania varied between 68 (95% CI: 61-76) and 318 (95% CI: 298-338) and between 23 (95% CI: 19-29) and 189 (95% CI: 149-240), respectively. The highest ILI and influenza incidence was among children aged 0-4 years. We estimated that SARI incidence per 100 000 persons was 6 (95% CI: 5-7) to 9 (95% CI: 8-10), of which 2 (95% CI: 1-2) to 3 (95% CI: 2-4) were due to influenza. Up to 0.3% of the Romanian population were annually reported with ILI, and 0.01% was hospitalized with SARI, of which as much as one-third could be explained by influenza.
CONCLUSIONS: This evaluation was the first study estimating influenza burden in Romania. We found that during each influenza season, a substantial number of persons in Romania suffer from influenza-related ILI or are hospitalized due to influenza-associated SARI.
© 2017 The World Health Organization. Influenza and Other Respiratory Viruses. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  burden; influenza-like illness; severe acute respiratory infection

Mesh:

Year:  2017        PMID: 29144598      PMCID: PMC5818344          DOI: 10.1111/irv.12525

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


INTRODUCTION

Influenza is a respiratory disease responsible for substantial increase in morbidity, mortality and costs during seasonal epidemics and pandemics.1, 2, 3, 4, 5, 6 The World Health Organization (WHO) estimates that annually seasonal influenza epidemics result in an estimated 3‐5 million cases of severe disease and 250 000‐500 00 deaths.7 However, the burden of seasonal influenza can vary between influenza seasons and countries. Therefore, reliable disease burden estimates are needed, especially from low‐ and middle‐income countries to provide a better understanding of the impact of influenza. Knowledge about influenza burden is crucial to further develop and strengthen influenza prevention strategies, as well as to assess utility. Thus, national estimates would enable governments, non‐governmental agencies, and others to make informed evidence‐based decisions when allocating limited resources dedicated to public health and planning intervention strategies to limit the spread of influenza. While some estimates of the national burden of influenza are available for countries of the WHO European Region, the majority of primary study estimates come from Western Europe and no estimates are available for over half of the member states.8, 9 Except for a study on the economic influenza burden among the elderly in 6 middle‐income countries of Central and Eastern Europe in 2010/11,9 influenza burden in the Romanian population has never been estimated. To gain insight into medically attended influenza burden on a national level, we performed an assessment of influenza disease burden due to influenza‐like illness (ILI) attendances and severe acute respiratory infection (SARI) hospitalizations associated with influenza in Romania at public facilities for the 2011/12‐2015/16 influenza seasons.

METHODS

This study followed the methods outlined in the WHO Manual, A Manual for Estimating Disease Burden Associated with Seasonal Influenza in a Population, using 5 years of Romania national surveillance data.10 The WHO European Region lies in the Northern Hemisphere, and the influenza season is considered to be from calendar week 40 to week 20 of the following calendar year.11 Romania performs influenza sentinel surveillance for ILI from week 40 to week 20 and for SARI from week 46 to week 20. Anonymous, routinely collected, retrospective national sentinel surveillance data on ILI and hospitalized SARI cases, including influenza‐associated deaths among SARI cases, were analysed for the 2011/12‐2015/16 influenza seasons. This included virological information obtained from testing of nasopharyngeal swabs for influenza virus using reverse transcription‐polymerase chain reaction (RT‐PCR). For the overview of the geographical distribution of the counties contributing to the ILI and SARI influenza sentinel surveillance, see Figure 1.
Figure 1

Influenza‐like illness (ILI) and severe acute respiratory infection (SARI) sentinel surveillance counties in Romania in 2015/16 influenza season

Influenza‐like illness (ILI) and severe acute respiratory infection (SARI) sentinel surveillance counties in Romania in 2015/16 influenza season

Influenza‐like illness sentinel surveillance and catchment population

From 2011/12‐2013/14 influenza seasons, sentinel ILI surveillance was conducted in all 41 counties and the capital city Bucharest. This included at least 270 general practitioners (GPs) from urban and rural areas with both adult and paediatric patients. This represented 1% of the GPs and covered approximately 2% of the population in Romania. These GP practices were selected by the counties' public health authorities and agreed to participate. Since 2014, sentinel ILI surveillance is performed in 15 counties and Bucharest and included at least 192 GPs. Cases were identified from patients who sought care at the clinic and those receiving home visits. In line with the WHO definition, ILI was defined as an acute respiratory infection with measured fever of ≥38°C and cough, with onset within the last 10 days.12 Samples for virological testing were collected 1 day per week (first two cases at each participating GP practice every Tuesday). Samples were only collected from ILI cases belonging to groups targeted for vaccination, including pregnant women, persons with underlying chronic conditions, aged >=65 years, HCWs, residents of long‐term care facilities. In Romania, the majority of the population is covered by a universal health insurance and registered with a GP practice. As these patients must seek care from the GPs with which they are registered, the catchment population was estimated by summing the patients registered at each participating GP practice.

Severe acute respiratory infection sentinel surveillance and catchment population

Since 2009, hospital‐based sentinel surveillance for SARI in Romania has been conducted in 20 university hospitals in 7 counties from all 4 geographical regions (Figure 1). A SARI case was defined as an acute respiratory infection with an onset in the previous 7 days requiring overnight hospitalization, history of fever or measured fever ≥38°C, cough and shortness of breath or difficulty breathing.11, 12 Starting with the 2013/14 season, the case definition was expanded to include an onset within the previous 10 days. Information on pregnancy status, underlying medical conditions and the outcome of the illness was also recorded for each SARI case. A subset of SARI cases was tested for influenza virus using RT‐PCR. The sampling algorithm for SARI cases had a two‐step approach with greater sampling early in the influenza season and decreased once influenza circulation had been identified. Starting in week 46, the first three identified SARI cases in each sentinel hospital were sampled per week. This sampling strategy continued until ≥10% of all the sentinel surveillance system samples (ILI and SARI) tested positive for the same influenza subtype/variant. Once the positivity rate by subtype/variant reached 10%, only the first identified SARI case in each sentinel hospital each week was sampled for the remainder of the influenza season. Because the catchment population for each hospital was unknown, an estimate was made by dividing the total number of all‐cause hospitalizations for each sentinel hospital by the total discharges (including deaths) from all the public hospitals in Romania to determine the proportion of all‐cause discharges for each sentinel hospital. This proportion was used as a proxy for the proportion of the population that sought care at each hospital and it was then multiplied by the Romanian population for each year to determine the catchment population for each sentinel site. The catchment population for all sites was summed to produce the estimate of the catchment population of all sentinel hospitals.

Statistical analysis

To estimate the annual incidence of ILI and SARI by type and subtype, we summed the weekly incidence in the sentinel sites of each influenza season and calculated their 95% confidence intervals by 1) calculating the error factor (EF), which was the exponentiation of 1.96 divided by the square root of number of (influenza‐associated) ILI or SARI cases, and 2) calculating the range of the 95% CI by dividing (higher CI) or multiplying (lower CI) the incidence by the EF, as described in WHO Manual.10 We stratified the ILI and influenza‐associated ILI incidence by age into 0‐4 years, 5‐14 years, 15‐64 years and 65 years and older groups. Due to limited availability of the hospital discharge data by different age groups, we were only able to stratify SARI and laboratory‐confirmed influenza‐associated SARI cases into paediatric (<16 years) and adult (≥16 years) age groups. All incidences were extrapolated to the Romanian population. We calculated case fatality proportion (CFP, %) among laboratory‐confirmed influenza‐associated SARI cases by dividing the number of laboratory‐confirmed influenza‐associated deaths among the SARI patients by the total laboratory‐confirmed influenza‐associated SARI cases and multiplying it by 100%. We estimated its 95% confidence interval by the Clopper‐Pearson method.13 The Romanian population size by age groups was extracted from the National Institute of Statistics in Romania as of January 1 for the years 2011‐2016 (http://www.insse.ro/cms/en). Approximately, 5% of the Romanian population was 0‐4 years old, 11% was 5‐14 years old, 68% was 15‐64 years old, and 16% was 65 years and older.

Ethical issues

The project was reviewed by the Ministry of Health of Romania and judged to be a public health evaluation. Only anonymized records were used for the analysis.

RESULTS

During the study period from the 2011/2012‐2015/2016, Romania experienced three seasonal influenza epidemics predominately due to influenza A virus and two seasons due to both influenza A and B (Table 1). One season was dominated by influenza A(H3) and two seasons by influenza A(H1N1)pdm09.
Table 1

Influenza by (sub)type, ILI and catchment population of the sentinel surveillance system by age in Romania in 2011/12‐2015/16 influenza seasons

SeasonInfluenzanILI casesn (% of the total ILI cases)Catchment populationN
A(H1N1)pdm09A(H3)BTotal specimensTotal positives n (%)0‐4 y5‐14 y15‐64 y≥65 yTotal0‐4 y5‐14 y15‐64 y≥65 yTotal
2011/1201821668183 (27.4)184 (23.1)164 (20.6)380 (47.6)70 (8.8)79845 62093 597432 558104 487676 261
2012/1345378454126 (27.8)134 (20.2)144 (21.7)352 (52.9)35 (5.3)66543 78988 172431 824102 810666 594
2013/1442793379127 (33.5)94 (20.5)72 (15.7)261 (57)31 (6.8)45841 49385 683439 629102 849669 653
2014/155610685445247 (55.5)176 (13.4)399 (30.4)649 (49.5)87 (6.6)131123 45654 348270 32162 107410 231
2015/161221816441156 (35.4)175 (20.7)245 (29)384 (45.5)40 (4.7)84423 00255 336271 22162 390411 948

ILI, influenza‐like illness.

Influenza by (sub)type, ILI and catchment population of the sentinel surveillance system by age in Romania in 2011/12‐2015/16 influenza seasons ILI, influenza‐like illness. The incidence of both ILI and influenza‐associated ILI was highest in children, especially children under 5 years of age (Table 2), where approximately 20% of ILI cases occurred (Table 1). The overall annual incidence of medically attended ILI at public GP practices per 100 000 population varied between seasons and was estimated to range from 68 (95% CI: 61‐76) to 318 (95% CI: 298‐338) cases, with the highest and lowest incidence recorded in 2013/14 and 2014/15, respectively (Table 2). When the results were extrapolated to the population, most of the ILI and influenza cases appeared in the 15‐ to 64‐year‐old group, which comprised approximately 68% of the Romanian population (Appendix 1). The lowest burden of ILI and influenza‐associated ILI was estimated in the cases 65 years old and older (Table 2). Influenza A(H1N1)pdm09 was responsible for the highest incidence of influenza‐associated ILI in 2015/16, influenza A(H3) in 2011/12 and 2013/14 and influenza type B in 2012/13 and 2013/14 influenza seasons (Table 2).
Table 2

Incidence of influenza by subtype, influenza‐associated ILI and ILI by age group per 100 000 population from sentinel surveillance in Romania in 2011/12‐2015/16 influenza seasons

Influenza‐associated ILI incidence per 100.000 (95% CI) by (sub)typeInfluenza‐associated ILI incidence per 100.000 (95% CI) by age groupILI incidence per 100.000 (95% CI) by age group
A(H1N1)pdm09A(H3)BTotal0‐4 y5‐14 y15‐64 y≥65 y0‐4 y5‐14 y15‐64 y≥65 yTotal
2011/1232 (27‐38)0 (0‐34)32 (27‐38)108 (90‐128)49 (41‐59)24 (20‐29)14 (12‐17)403 (337‐480)175 (145‐211)88 (78‐99)67 (50‐91)118 (108‐128)
2012/1312 (8‐18)1 (0‐8)23 (18‐31)36 (4‐331)82 (66‐102)68 (7‐621)31 (3‐286)10 (1‐92)304 (247‐375)162 (132‐198)81 (72‐92)34 (22‐53)99 (91‐109)
2013/148 (5‐11)15 (11‐20)0 (0‐4)23 (19‐29)70 (56‐87)29 (23‐36)21 (17‐26)10 (8‐12)225 (175‐291)84 (62‐112)59 (51‐68)30 (19‐49)68 (61‐76)
2014/1541 (29‐58)70 (55‐89)78 (60‐102)189 (149‐240)395 (340‐460)439 (346‐557)146 (115‐185)81 (63‐102)748 (624‐896)730 (649‐821)238 (218‐261)139 (107‐182)318 (298‐338)
2015/1653 (43‐66)5 (3‐11)12 (6‐24)71 (58‐86)207 (170‐251)139 (115‐169)56 (46‐68)22 (18‐27)759 (633‐911)443 (380‐515)142 (126‐160)64 (42‐96)205 (189‐221)

ILI: influenza‐like illness.

95% CI: 95% confidence interval.

Incidence of influenza by subtype, influenza‐associated ILI and ILI by age group per 100 000 population from sentinel surveillance in Romania in 2011/12‐2015/16 influenza seasons ILI: influenza‐like illness. 95% CI: 95% confidence interval. On average, approximately 27%‐56% of ILI cases in Romania could be explained by influenza (Table 1), and positivity among the SARI cases also varied over influenza seasons 24%‐43% (Table 3). Influenza‐associated SARI incidence was higher among the <16‐year‐old cases, except for 2014/2015 and 2015/16 influenza seasons, when the incidence appeared to be higher in the ≥16‐year‐old cases. Influenza A(H1N1)pdm09 was responsible for the highest incidence in 2012/13 and 2015/16, influenza A(H3) in 2011/12 and 2013/14 and influenza B in 2014/15 season (Table 4). We estimated that annually approximately 1118 (95% CI: 956‐1308) to 2059 (95% CI: 1839‐2304) persons are hospitalized at public hospitals due to SARI, of which 317 (95% CI: 232‐434) to 625 (95% CI 505‐774) are due to influenza (Appendix 2). The CFP for influenza‐positive SARI cases varied from 1% (95% CI: 0‐8) to 40% (95% CI: 29‐51) in 2011/12 and 2015/16, respectively (Table 5).
Table 3

Influenza‐positive deaths, influenza‐positive SARI cases, sampled SARI cases and total numbers of SARI cases, SARI catchment population of the sentinel surveillance in Romania by paediatric and adult age groups in 2011/12‐2015/16 influenza seasons

Influenza‐positive deathsInfluenza‐positive SARI casesSampled SARI casesSARI casesSARI catchment population
<16 ys≥16 yTotal<16 y≥16 yTotal<16 y≥16 yTotal<16 y≥16 yTotal<16 y≥16 yTotal
2011/12101313869175108283235111346944 8652 924 1053 951 305
2012/132192129871161951873822371914281 011 6573 083 2024 177 965
2013/14211131845631101122221181122301 007 0983 050 1824 119 027
2014/1512122291311601402353751462463921 568 9884 034 6675 708 912
2015/1643135177188791602391153284431 559 7334 072 5285 754 807

SARI, severe acute respiratory infection.

Table 4

Incidence of SARI and influenza‐associated SARI by virus (sub)type and paediatric and adult age group per 100 000 population in Romania in 2011/12‐2015/16 influenza seasons

Influenza‐associated SARI incidence per 100.000 (95% CI) by virus (sub)type and age groupSARI incidence per 100.000 (95% CI) by age group
A(H1N1)pdm09A(H3)B<16 y≥16 yTotal<16 y≥16 yTotal
2011/122.1 (1.6‐2.8)0 (0‐2.5)4.4 (2.9‐6.6)1.3 (0.9‐2)2.1 (1.6‐2.8)24.9 (21.3‐29)3.8 (3‐4.8)8.8 (7.7‐9.9)
2012/132.1 (0‐2.7)0.1 (0‐0.8)1 (0.7‐1.5)3.5 (2.2‐5.4)2.9 (2.2‐3.7)3.1 (2.5‐3.9)23.4 (20.1‐27.3)6.2 (5.2‐7.4)10.2 (9.2‐11.5)
2013/140.8 (0‐1.2)0.9 (0.5‐1.3)1.9 (1‐3.6)1.5 (1‐2.2)1.6 (1.2‐2.2)11.7 (9.4‐14.7)3.7 (2.9‐4.6)5.6 (4.8‐6.5)
2014/150.9 (0‐1.3)0.9 (0.6‐1.2)1.2 (0.9‐1.6)1.9 (1.2‐3.1)3.4 (2.8‐4.2)2.9 (2.4‐3.5)9.3 (7.6‐11.4)6.1 (5.2‐7.1)6.9 (6.1‐7.7)
2015/162.6 (0‐3.2)0 (0‐0.8)0.2 (0.1‐0.4)1.6 (0.9‐2.7)3.6 (2.9‐4.4)2.8 (2.3‐3.4)7.4 (5.9‐9.3)8.1 (7.1‐9.2)7.7 (6.9‐8.6)

SARI, severe acute respiratory infection.

95% CI: 95% confidence interval.

Table 5

Hospital CFP among influenza‐associated laboratory‐confirmed SARI cases by year in Romania in 2011/12‐2015/16 influenza seasons

Influenza seasonCFP %(95% CI)CFP % (95% CI)CFP % (95% CI)
<16 y≥16 yTotal
2011/123.2 (0.1‐16.7)0 (0‐10.9)1.4 (0‐7.8)
2012/136.9 (0.8‐22.8)21.8 (13.7‐32)18.1 (11.6‐26.3)
2013/1411.1 (1.4‐34.7)24.4 (12.9‐39.5)20.6 (11.5‐32.7)
2014/153.4 (0.1‐17.8)16 (10.2‐23.5)13.8 (8.8‐20.1)
2015/1623.5 (6.8‐49.9)43.7 (31.9‐56)39.8 (29.5‐50.8)

CFP, case fatality proportion; SARI, severe acute respiratory infection.

95% CI: 95% confidence interval.

Influenza‐positive deaths, influenza‐positive SARI cases, sampled SARI cases and total numbers of SARI cases, SARI catchment population of the sentinel surveillance in Romania by paediatric and adult age groups in 2011/12‐2015/16 influenza seasons SARI, severe acute respiratory infection. Incidence of SARI and influenza‐associated SARI by virus (sub)type and paediatric and adult age group per 100 000 population in Romania in 2011/12‐2015/16 influenza seasons SARI, severe acute respiratory infection. 95% CI: 95% confidence interval. Data on the rate of influenza in pregnant women with ILI were only available for the 2015/2016 influenza season. Of the 156 influenza‐positive ILI cases in 2015/16, 4 of 97 (5%) occurred in pregnant women (none of them vaccinated), and 31 of 156 (20%) in patients who were suffering from the underlying medical conditions. Among influenza‐positive SARI cases during 2011/2012‐2015/2016, approximately 1%‐7% were pregnant and 51%‐66% suffered from underlying medical conditions. None of the pregnant women were vaccinated, and approximately 2% of those suffering from the underlying medical conditions were vaccinated. It was not possible to calculate the incidence for these groups as the catchment population for these target groups was not known.

DISCUSSION

Our results suggest that influenza is associated with substantial morbidity in terms of primary care attendances due to ILI and hospitalizations due to SARI in Romania. In total, at least 13 621‐63 373 ILI cases and 1118‐2059 hospitalizations due to SARI were estimated to occur annually in Romania during different influenza seasons. The highest influenza‐associated ILI incidence estimates of 70‐395 cases per 100 000 depending on the influenza season were found in children aged 0‐4 years. Except for the 2014/15 influenza season when both influenza A and influenza B were circulating, children aged 0‐4 years had the highest incidence and more influenza‐associated ILI visits than those aged 5‐14 years, which was consistent with previous estimates coming from Europe and the USA.14, 15 Due to differences in surveillance systems, case definitions, access to care and healthcare‐seeking behaviour, direct comparisons of the incidence rates are not possible; however, similar trends were observed. As in previous reports,16, 17 the incidence of SARI was higher among younger (<16 years old) than older cases (≥16 years old) except for 2015/16 season, a season dominated by A(H1N1)pdm09 when the incidence of SARI was higher in the older cases (≥16 years old). The incidence of influenza‐associated SARI was similar between the age groups for all seasons except 2011/2012, when the rate in the <16‐year‐old group was 4 times higher than the older group. Overall, there was higher incidence of influenza‐related ILI in 2014/2015 season with cocirculation of all 3 viruses with increased incidence in all age groups. Our results showed that the CFP of hospitalized laboratory‐confirmed cases varied from 1% in the 2011/12 season to 40% in the 2015/16 with a median of 18%. This is similar to what was reported by18 from a study of SARI in the WHO European Region from 2009/2010 to 2011/2012 where 6 countries (Albania, Armenia, Georgia, Kazakhstan, Romania, and Ukraine) report CFP for laboratory‐confirmed SARI cases18. The CFP varied from 0%‐70%, but in over half of the seasons, the CFP was <2%. The high CFP of 14%‐40% seen in this study may represent all SARI cases; however, it is also possible that participating clinicians were more likely to test severe or critical cases, which inflated the estimates. The CFP for SARI cases in this study is similar to what has been reported from influenza SARI and all influenza cases in intensive care units (ICU) in other countries in Europe. In Spain, the CFP in laboratory‐confirmed SARI ICU cases for 2011/2012‐2013/2014 seasons was 15%,19 while in France the CFP of laboratory‐confirmed influenza cases in the ICU in 2010/2011‐2012/2013 ranged from 16%‐19%,20 and in Greece, during the 2010/2011 (post‐pandemic) season, the CFP was 39%.21 This could be explained by more patients being recruited in critical condition, when they were more likely to die, while others, less severe, might not have been captured; however, this does not explain the large variability between seasons. Using the Romanian influenza sentinel system, we were able to estimate clinical burden of ILI and SARI, including the proportion attributable to influenza. In order to compare influenza disease burden to other countries in the region, we therefore used methodology proposed by the WHO10 to estimate influenza burden in Romania. Hospital CFP among influenza‐associated laboratory‐confirmed SARI cases by year in Romania in 2011/12‐2015/16 influenza seasons CFP, case fatality proportion; SARI, severe acute respiratory infection. 95% CI: 95% confidence interval.

Limitations

This study sought to estimate the burden of influenza at public healthcare facilities in Romania. Persons who went to private clinics or hospitals were not assessed by the national influenza surveillance system. The true number of persons who did not seek care under the universal health insurance scheme in Romania is unknown, but estimated to be <20% of the population (personal communication, Odette Popovici, 2017). Therefore, our findings are likely to be an underrepresentation of the true medically attended ILI burden of disease in Romania by up to 20% of ILI cases. This study relied on data from the national influenza sentinel surveillance system, which has been collecting ILI and SARI data in Romania since 2009. These data were collected for public health purposes relying on data voluntarily collected from clinicians to detect and report cases in addition to their normal duties, and may be limited in comparison with data collected in targeted research programmes. Although steps were taken to minimize potential bias, the surveillance system consisted of many doctors from numerous sites. Differences in adherence to protocols, hospitalization practices and patient healthcare‐seeking behaviour could not be accounted for in the analysis. Samples for influenza testing for ILI cases were only collected from patients who belonged to the risk groups targeted for vaccination in Romania. In this analysis, we used the per cent of the influenza‐positive ILI cases from these vaccine target groups to estimate the influenza positivity for all ILI cases. If these cases from the vaccine target groups were more likely to be influenza positive on testing, then we may have overestimated the ILI rates. Unfortunately, it was not possible to determine the incidence in the risk groups as the Romanian population for each risk group was not known. Also, the number of pregnant women in the surveillance sites was very low, so we were not able to estimate influenza burden in this specific group. Although influenza has been shown to cause severe disease at higher incidence in the very young and the elderly,7 we were not able to examine the incidence in these age groups. We were only able to calculate the SARI incidence for children less than 16 years of age and all adults (≥16 years old), because hospital discharge data were only available for these groups. In addition, very low vaccination uptake rates among the cases registered by the surveillance system did not allow us to estimate influenza burden between the vaccinated and the unvaccinated individuals. During the study period, two changes were made to the sentinel surveillance system protocol. Starting in the 2014/2015 season, the number of primary care sites participating in influenza surveillance decreased to 195 GPs. While the absolute number of ILI and influenza‐associated ILI were impacted by the change in the protocol, it is unlikely to have impacted the rates. The case definition for SARI changed in 2013/2014 expanding the time since the onset of disease to 10 days. This could have allowed more people to be considered as SARI cases, especially as there may be a delay from onset until a person is admitted to hospital. However, this change in case definition does not appear to have resulted in an overall increase SARI or influenza‐associated SARI incidence. Only the first 2 patients presenting with ILI symptoms every Tuesday at each primary care site and 1‐3 cases with SARI per hospital were sampled. This may not have been a sufficient number to adequately represent the relative intensity of influenza activity and to refine per cent positive influenza cases needed for estimation of the influenza‐associated ILI and SARI in Romania, especially during the height of the influenza season when the relative sampling fraction is lowest. A systematic evaluation of the national sentinel surveillance system would provide information on adherence to case definitions and protocol, optimization of sampling strategy to meet system objectives and system quality. This enhanced understanding of the sentinel surveillance system data would assist when future studies are performed to assess influenza burden in the groups targeted for influenza vaccination in Romania and the cost‐effectiveness of influenza vaccination.

CONCLUSION

This evaluation using the recently proposed methodology by WHO10 was the first study estimating influenza burden in Romania. We found that during each influenza season, a substantial number of persons in Romania suffer from influenza‐related ILI or are hospitalized due to influenza‐associated SARI. This information will be used to support influenza prevention campaigns during the influenza season in Romania to improve vaccination uptake and increase awareness of influenza prevention and treatment.

CONFLICT OF INTERESTS

GG, AP, RP, OP, DC, MJ and DG have no conflict of interest to declare. CDs appointment is partly supported by grants of different pharmaceutical companies, including companies involved in the subject matter of this study.
SeasonInfluenza‐associated ILI incidence in the Romanian population (95% CI)ILI incidence in the Romanian population (95% CI)Total population in Romania
A(H1N1)pdm09A(H3)B0‐4 y5‐14 y15‐64 y≥65 yTotal0‐4 y5‐14 y15‐64 y≥65 yTotal
2011/126397 (5355‐7640)38 (0‐6879)1058 (886‐1263)966 (809‐1153)3458 (2897‐4128)435 (365‐520)6435 (5390‐7682)4226 (3541‐5042)3759 (3115‐4536)12 035 (10 675‐13 570)2183 (2168‐2198)23 765 (21 908‐25 781)20 199 059
2012/132443 (1660‐3596)172 (19‐1567)4672 (3521‐6200)803 (88‐7329)1329 (146‐12 138)4406 (483‐40 228)313 (34‐2856)7287 (798‐66 536)3154 (2557‐3890)3475 (2840‐4251)11 095 (9792‐12 572)1102 (1094‐1110)19 957 (18 248‐21 825)20 095 996
2013/141510 (1010‐2258)3048 (2302‐4037)92 (10‐839)677 (545‐840)562 (453‐698)2964 (2388‐3679)308 (248‐383)4684 (3774‐5813)2257 (1749‐2912)1786 (1329‐2401)8043 (6948‐9312)979 (972‐986)13 621 (12 217‐15 186)20 020 074
2014/158195 (5828‐11 525)13959 (10996‐17 720)15 552 (11 877‐20 365)3824 (3012‐4854)8489 (6687‐10 776)20 281 (15 977‐25 746)2466 (1943‐3131)37 550 (29 581‐47 668)7251 (6051‐8689)15 560 (13 843‐17 490)32 318 (29 518‐35 384)4594 (4553‐4635)63 373 (59 505‐67 491)19 953 089
2015/1610 570 (8475‐13 182)1086 (558‐2115)2359 (1152‐4830)1998 (1647‐2423)2698 (2224‐3272)7791 (6423‐9451)686 (566‐833)14 015 (11 553‐17 000)7270 (6063‐8716)9401 (8080‐10 939)18 991 (16 855‐21 399)2149 (2130‐2169)40 656 (37 565‐44 000)19 870 647

ILI, influenza‐like illness.95% CI: 95% confidence interval.

Influenza‐associated SARI incidence in the Romanian population (95% CI)SARI in the Romanian population (95% CI)
<16 y≥16 yTotal<16 y≥16 yTotal
2011/12130 (87‐195)230 (151‐350)431 (329‐565)733 (628‐856)655 (519‐826)1769 (1559‐2006)
2012/13102 (65‐160)495 (380‐643)625 (505‐774)687 (589‐802)1063 (894‐1264)2059 (1839‐2304)
2013/1456 (30‐106)252 (171‐371)317 (232‐434)342 (273‐429)628 (498‐791)1118 (956‐1308)
2014/1556 (34‐91)579 (471‐712)584 (485‐704)271 (222‐331)1039 (893‐1208)1370 (1217‐1541)
2015/1646 (27‐80)606 (496‐741)563 (466‐680)214 (170‐269)1367 (1200‐1556)1530 (1369‐1709)

SARI, severe acute respiratory infection.95% CI: 95% confidence interval.

  17 in total

Review 1.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; W Abdullah Brooks; Mark Katz; Anna Roca; James A Berkley; Shabir A Madhi; James Mark Simmerman; Aubree Gordon; Masatoki Sato; Stephen Howie; Anand Krishnan; Maurice Ope; Kim A Lindblade; Phyllis Carosone-Link; Marilla Lucero; Walter Ochieng; Laurie Kamimoto; Erica Dueger; Niranjan Bhat; Sirenda Vong; Evropi Theodoratou; Malinee Chittaganpitch; Osaretin Chimah; Angel Balmaseda; Philippe Buchy; Eva Harris; Valerie Evans; Masahiko Katayose; Bharti Gaur; Cristina O'Callaghan-Gordo; Doli Goswami; Wences Arvelo; Marietjie Venter; Thomas Briese; Rafal Tokarz; Marc-Alain Widdowson; Anthony W Mounts; Robert F Breiman; Daniel R Feikin; Keith P Klugman; Sonja J Olsen; Bradford D Gessner; Peter F Wright; Igor Rudan; Shobha Broor; Eric A F Simões; Harry Campbell
Journal:  Lancet       Date:  2011-11-10       Impact factor: 79.321

2.  Influenza surveillance during the post-pandemic influenza 2010/11 season in Greece, 04 October 2010 to 22 May 2011.

Authors:  M Athanasiou; A Baka; A Andreopoulou; G Spala; K Karageorgou; L Kostopoulos; S Patrinos; T Sideroglou; E Triantafyllou; A Mentis; N Malisiovas; T Lytras; S Tsiodras; T Panagiotopoulos; S Bonovas
Journal:  Euro Surveill       Date:  2011-11-03

Review 3.  Influenza cost and cost-effectiveness studies globally--a review.

Authors:  Samuel K Peasah; Eduardo Azziz-Baumgartner; Joseph Breese; Martin I Meltzer; Marc-Alain Widdowson
Journal:  Vaccine       Date:  2013-09-19       Impact factor: 3.641

4.  Influenza infection in the intensive care unit: Four years after the 2009 pandemic.

Authors:  Marcos Pérez-Carrasco; Leonel Lagunes; Andrés Antón; Simone Gattarello; César Laborda; Tomás Pumarola; Jordi Rello
Journal:  Enferm Infecc Microbiol Clin       Date:  2015-05-27       Impact factor: 1.731

5.  Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project.

Authors:  W John Paget; Catherine Balderston; Inmaculada Casas; Gé Donker; Laurel Edelman; Douglas Fleming; Amparo Larrauri; Adam Meijer; Simona Puzelli; Caterina Rizzo; Lone Simonsen
Journal:  Eur J Pediatr       Date:  2010-03-13       Impact factor: 3.183

6.  Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons.

Authors:  Isabelle Bonmarin; Emmanuel Belchior; Jean Bergounioux; Christian Brun-Buisson; Bruno Mégarbane; Jean Loup Chappert; Bruno Hubert; Yann Le Strat; Daniel Lévy-Bruhl
Journal:  Euro Surveill       Date:  2015

Review 7.  A systematic review of the social and economic burden of influenza in low- and middle-income countries.

Authors:  Natasha de Francisco Shapovalova; Morgane Donadel; Mark Jit; Raymond Hutubessy
Journal:  Vaccine       Date:  2015-10-25       Impact factor: 3.641

8.  Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study.

Authors:  Rhys D Pockett; John Watkins; Phil McEwan; Genevieve Meier
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

9.  Medical and economic burden of influenza in the elderly population in central and eastern European countries.

Authors:  Gábor Kovács; Zoltán Kaló; Karina Jahnz-Rozyk; Jan Kyncl; Agnes Csohan; Adriana Pistol; Mariya Leleka; Rafail Kipshakbaev; Laure Durand; Bérengère Macabeo
Journal:  Hum Vaccin Immunother       Date:  2013-10-28       Impact factor: 3.452

Review 10.  Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis.

Authors:  Kathryn E Lafond; Harish Nair; Mohammad Hafiz Rasooly; Fátima Valente; Robert Booy; Mahmudur Rahman; Paul Kitsutani; Hongjie Yu; Guiselle Guzman; Daouda Coulibaly; Julio Armero; Daddi Jima; Stephen R C Howie; William Ampofo; Ricardo Mena; Mandeep Chadha; Ondri Dwi Sampurno; Gideon O Emukule; Zuridin Nurmatov; Andrew Corwin; Jean Michel Heraud; Daniel E Noyola; Radu Cojocaru; Pagbajabyn Nymadawa; Amal Barakat; Adebayo Adedeji; Marta von Horoch; Remigio Olveda; Thierry Nyatanyi; Marietjie Venter; Vida Mmbaga; Malinee Chittaganpitch; Tran Hien Nguyen; Andros Theo; Melissa Whaley; Eduardo Azziz-Baumgartner; Joseph Bresee; Harry Campbell; Marc-Alain Widdowson
Journal:  PLoS Med       Date:  2016-03-24       Impact factor: 11.069

View more
  11 in total

1.  Burden of influenza in Romania. A retrospective analysis of 2014/15 - 2018/19 seasons in Romania.

Authors:  Adrian Pană; Adriana Pistol; Adrian Streinu-Cercel; Bogdan-Vasile Ileanu
Journal:  Germs       Date:  2020-09-01

2.  [Clinical characteristics of influenza pneumonia in the elderly and relationship between D-dimer and disease severity].

Authors:  J Li; Y Xu; Y Y Wang; Z C Gao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-18

3.  Estimating burden of influenza-associated influenza-like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12-2015/16 influenza seasons.

Authors:  Giedre Gefenaite; Adriana Pistol; Rodica Popescu; Odette Popovici; Daniel Ciurea; Christiaan Dolk; Mark Jit; Diane Gross
Journal:  Influenza Other Respir Viruses       Date:  2017-12-15       Impact factor: 4.380

4.  Advances in measuring influenza burden of disease.

Authors:  Vernon J Lee; Zheng Jie Marc Ho; Ee Hui Goh; Harry Campbell; Cheryl Cohen; Vanessa Cozza; Julia Fitzner; Jorge Jara; Anand Krishnan; Joseph Bresee
Journal:  Influenza Other Respir Viruses       Date:  2018-01       Impact factor: 4.380

5.  Burden of influenza-associated outpatient influenza-like illness consultations in China, 2006-2015: A population-based study.

Authors:  Luzhao Feng; Shuo Feng; Tao Chen; Juan Yang; Yiu Chung Lau; Zhibin Peng; Li Li; Xiling Wang; Jessica Y T Wong; Ying Qin; Helen S Bond; Juanjuan Zhang; Vicky J Fang; Jiandong Zheng; Jing Yang; Peng Wu; Hui Jiang; Yangni He; Benjamin J Cowling; Hongjie Yu; Yuelong Shu; Eric H Y Lau
Journal:  Influenza Other Respir Viruses       Date:  2019-12-23       Impact factor: 4.380

6.  Estimates of influenza-associated hospitalisations in tropical Singapore, 2010-2017: Higher burden estimated in more recent years.

Authors:  Yixiang Ng; Lily Ai Vee Chua; Stefan Ma; Vernon Jian Ming Lee
Journal:  Influenza Other Respir Viruses       Date:  2019-08-21       Impact factor: 4.380

7.  Surveillance of medically-attended influenza in elderly patients from Romania-data from three consecutive influenza seasons (2015/16, 2016/17, and 2017/18).

Authors:  Daniela Pițigoi; Anca Streinu-Cercel; Alina Elena Ivanciuc; Mihaela Lazãr; Carmen Maria Cherciu; Maria Elena Mihai; Maria Nițescu; Victoria Aramă; Maria Dorina Crăciun; Adrian Streinu-Cercel; Oana Săndulescu
Journal:  Influenza Other Respir Viruses       Date:  2020-05-15       Impact factor: 4.380

8.  The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis.

Authors:  A C Teirlinck; B de Gier; A Meijer; G Donker; M de Lange; C Koppeschaar; W van der Hoek; M E Kretzschmar; S A McDonald
Journal:  Epidemiol Infect       Date:  2018-10-23       Impact factor: 2.451

9.  The 2017-2018 influenza season in Bucharest, Romania: epidemiology and characteristics of hospital admissions for influenza-like illness.

Authors:  Anca Drăgănescu; Oana Săndulescu; Dragoș Florea; Ovidiu Vlaicu; Anca Streinu-Cercel; Dan Oțelea; Monica Luminița Luminos; Victoria Aramă; Sorin Abrudan; Adrian Streinu-Cercel; Daniela Pițigoi
Journal:  BMC Infect Dis       Date:  2019-11-12       Impact factor: 3.090

10.  Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study.

Authors:  Sierk D Marbus; Valentijn A Schweitzer; Geert H Groeneveld; Jan J Oosterheert; Peter M Schneeberger; Wim van der Hoek; Jaap T van Dissel; Arianne B van Gageldonk-Lafeber; Marie-Josée Mangen
Journal:  Eur J Health Econ       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.